Search

everythinglearnresearchcommunity

for

Search:↓

Being allergic to linalool, a common fragrance ingredient, might contribute to developing frontal fibrosing alopecia.

Myofibroblasts in rat wound healing may come from blood vessel pericytes and perifollicular dermal sheath cells.

Injecting stem cells from a patient's own fat can improve hair growth in women with hair loss.

Mast cells may significantly contribute to central centrifugal cicatricial alopecia.

A hairless patch on a boy's scalp from birth injury improved with minoxidil treatment.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

A premenopausal woman had hair loss and skin issues, treated with topical steroids.

Mast cells might contribute to hair loss by causing skin thickening.

The document concludes that there are no reliable treatments for frontal fibrosing alopecia, with only temporary benefits from current options.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

Hair transplantation may not work for Frontal Fibrosing Alopecia as transplanted hair was lost when the disease came back.

Low-dose oral isotretinoin improved hair loss and facial bumps in patients with a specific type of hair loss.

Stopping sunscreen use on the forehead led to hair regrowth in a woman with frontal fibrosing alopecia.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

The study found that Frontal Fibrosing Alopecia affects a broader age range of women and early treatment can help stop hair loss.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

FFA's causes may include environmental triggers and genetic factors.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

Dermoscopy helps diagnose frontal fibrosing alopecia by distinguishing it from other hair loss conditions.

Treatments for Frontal Fibrosing Alopecia have not been proven effective.

Some treatments can stabilize Frontal Fibrosing Alopecia, but more research is needed to find effective treatments, and hair transplants often fail.

Inflammation around hair follicles may worsen hair loss; evaluating and treating it can improve transplant results.

Plasma Rich in Growth Factors may help reduce hair loss in Frontal Fibrosing Alopecia.

Frontal fibrosing alopecia is linked to hypothyroidism but doesn't affect quality of life.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Apremilast may help treat lichen planopilaris and frontal fibrosing alopecia when other treatments fail.

A lotion with minoxidil, hydrocortisone butyrate, and 17a-estradiol can improve or stabilize Frontal Fibrosing Alopecia in some cases, but there's no universally-accepted treatment yet.